文献速递自身炎症与 IgG4 相关病

血清IL-18升高可区分PSTPIP1致病突变患者

Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1.
PubMed 文献 · Arthritis Rheumatol · 2022-01-03

研究比较PSTPIP1突变阳性与阴性PAPA样症状患者的临床和血清学特征,发现突变阳性者起病更早、关节炎比例更高,且血清总IL-18持续显著升高,但无MAS病史。提示PAPA综合征与IL-18慢性升高相关,但不增加MAS风险。

要点

  • PSTPIP1突变阳性PAPA患者血清总IL-18普遍升高且持续存在。
  • PAPA患者可检测到游离IL-18,IL-18BP仅轻度升高。
  • PAPA综合征罕见CXCL9升高,无MAS病史。

核心结论

  • PAPA综合征是与血清IL-18慢性且无对抗性升高相关的难治性单基因自身炎症性疾病,但不增加MAS风险。

研究设计与样本

  • 研究纳入因PAPA综合征疑似症状转诊的患者,获取临床和遗传数据及血清样本。
  • 采用珠基法检测血清IL-18、IL-18BP和CXCL9水平,ELISA检测游离IL-18。

主要发现

  • PSTPIP1阳性PAPA患者症状与突变阴性PAPA样患者重叠,但阳性患者起病更早且关节炎病史比例更高。
  • 未经治疗或治疗中的PAPA患者血清总IL-18普遍升高,水平接近NLRC4相关婴儿小肠结肠炎自身炎症患者,远高于大多数家族性地中海热患者。
  • PAPA患者血清IL-18升高在疾病活动度波动时持续存在。
  • 可溶性IL-18拮抗剂IL-18BP仅轻度升高,PAPA患者可检测到游离IL-18。
  • PAPA综合征罕见CXCL9升高,且无PAPA患者有MAS病史。

临床怎么用

  • 对疑似PAPA综合征患者,血清IL-18持续升高可支持PSTPIP1致病突变相关诊断。
  • PAPA综合征患者需关注关节炎等表现,但MAS风险未见增加。

局限性

  • 原文未明确报告样本量、具体数值、P值及置信区间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Dominantly inherited PSTPIP1 mutations cause a spectrum of autoinflammatory manifestations epitomized by PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.). The connections between PSTPIP1 and PAPA syndrome are poorly understood, although evidence suggests involvement of pyrin inflammasome activation. Interleukin-18 (IL-18) is an inflammasome-activated cytokine associated with susceptibility to macrophage activation syndrome (MAS). This study was undertaken to investigate an association of IL-18 with PAPA syndrome. METHODS: Clinical and genetic data and serum samples were obtained from patients referred to institutions due to symptoms indicative of PAPA syndrome. Serum IL-18, IL-18 binding protein (IL-18BP), and CXCL9 levels were assessed by bead-based assay, and free IL-18 levels were assessed by enzyme-linked immunosorbent assay. RESULTS: The symptoms of PSTPIP1-positive patients with PAPA syndrome overlapped with those of mutation-negative patients with PAPA-like conditions, but mutation-positive patients had earlier onset and a greater proportion had a history of arthritis. We found uniform elevation of total serum IL-18 in treated PAPA syndrome patients at levels nearly as high as those seen in NLRC4-associated autoinflammation with infantile enterocolitis patients, and well above levels found in most familial Mediterranean fever patients. Serum IL-18 elevation in PAPA syndrome patients persisted despite fluctuations in disease activity. Levels of the soluble IL-18 antagonist IL-18BP were modestly elevated, and PAPA syndrome patients had detectable free IL-18. PAPA syndrome was rarely associated with elevation of CXCL9, an indicator of interferon-γ activity, but no PAPA syndrome patients had a history of MAS. CONCLUSION: PAPA syndrome is a refractory and often disabling monogenic autoinflammatory disease associated with chronic and unopposed elevation of serum IL-18 levels but not with risk of MAS. These findings affect our understanding of the diseases in which IL-18 is overproduced and suggest a link between pyrin inflammasome activation, IL-18, and autoinflammation, without susceptibility to MAS.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Stone DL, Ombrello A, Arostegui JI, et al. Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1. Arthritis Rheumatol. 2022. PMID: 34492165. doi:10.1002/art.41976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。